Report Detail
Global Estradiol Transdermal System Market Professional Survey Report 2019
- RnM3800597 |
- 03 October, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
The global Estradiol Transdermal System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Estradiol Transdermal System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Estradiol Transdermal System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Estradiol Transdermal System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Estradiol Transdermal System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day
Segment by Application
Hot flashes
Prevention of postmenopausal osteoporosis
Treatment of hypoestrogenism
Moderate-to-severe vasomotor symptoms
Others
Table of Contents
Executive Summary
1 Industry Overview of Estradiol Transdermal System
- 1.1 Definition of Estradiol Transdermal System
- 1.2 Estradiol Transdermal System Segment by Type
- 1.2.1 Global Estradiol Transdermal System Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 0.025 mg per day
- 1.2.3 0.0375 mg per day
- 1.2.4 0.05 mg per day
- 1.2.5 0.075 mg per day
- 1.2.6 0.1 mg per day
- 1.3 Estradiol Transdermal System Segment by Applications
- 1.3.1 Global Estradiol Transdermal System Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hot flashes
- 1.3.3 Prevention of postmenopausal osteoporosis
- 1.3.4 Treatment of hypoestrogenism
- 1.3.5 Moderate-to-severe vasomotor symptoms
- 1.3.6 Others
- 1.4 Global Estradiol Transdermal System Overall Market
- 1.4.1 Global Estradiol Transdermal System Revenue (2014-2025)
- 1.4.2 Global Estradiol Transdermal System Production (2014-2025)
- 1.4.3 North America Estradiol Transdermal System Status and Prospect (2014-2025)
- 1.4.4 Europe Estradiol Transdermal System Status and Prospect (2014-2025)
- 1.4.5 China Estradiol Transdermal System Status and Prospect (2014-2025)
- 1.4.6 Japan Estradiol Transdermal System Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Estradiol Transdermal System Status and Prospect (2014-2025)
- 1.4.8 India Estradiol Transdermal System Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Estradiol Transdermal System
- 2.3 Manufacturing Process Analysis of Estradiol Transdermal System
- 2.4 Industry Chain Structure of Estradiol Transdermal System
3 Development and Manufacturing Plants Analysis of Estradiol Transdermal System
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Estradiol Transdermal System Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Estradiol Transdermal System
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Estradiol Transdermal System Production and Capacity Analysis
- 4.2 Estradiol Transdermal System Revenue Analysis
- 4.3 Estradiol Transdermal System Price Analysis
- 4.4 Market Concentration Degree
5 Estradiol Transdermal System Regional Market Analysis
- 5.1 Estradiol Transdermal System Production by Regions
- 5.1.1 Global Estradiol Transdermal System Production by Regions
- 5.1.2 Global Estradiol Transdermal System Revenue by Regions
- 5.2 Estradiol Transdermal System Consumption by Regions
- 5.3 North America Estradiol Transdermal System Market Analysis
- 5.3.1 North America Estradiol Transdermal System Production
- 5.3.2 North America Estradiol Transdermal System Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Estradiol Transdermal System Import and Export
- 5.4 Europe Estradiol Transdermal System Market Analysis
- 5.4.1 Europe Estradiol Transdermal System Production
- 5.4.2 Europe Estradiol Transdermal System Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Estradiol Transdermal System Import and Export
- 5.5 China Estradiol Transdermal System Market Analysis
- 5.5.1 China Estradiol Transdermal System Production
- 5.5.2 China Estradiol Transdermal System Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Estradiol Transdermal System Import and Export
- 5.6 Japan Estradiol Transdermal System Market Analysis
- 5.6.1 Japan Estradiol Transdermal System Production
- 5.6.2 Japan Estradiol Transdermal System Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Estradiol Transdermal System Import and Export
- 5.7 Southeast Asia Estradiol Transdermal System Market Analysis
- 5.7.1 Southeast Asia Estradiol Transdermal System Production
- 5.7.2 Southeast Asia Estradiol Transdermal System Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Estradiol Transdermal System Import and Export
- 5.8 India Estradiol Transdermal System Market Analysis
- 5.8.1 India Estradiol Transdermal System Production
- 5.8.2 India Estradiol Transdermal System Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Estradiol Transdermal System Import and Export
6 Estradiol Transdermal System Segment Market Analysis (by Type)
- 6.1 Global Estradiol Transdermal System Production by Type
- 6.2 Global Estradiol Transdermal System Revenue by Type
- 6.3 Estradiol Transdermal System Price by Type
7 Estradiol Transdermal System Segment Market Analysis (by Application)
- 7.1 Global Estradiol Transdermal System Consumption by Application
- 7.2 Global Estradiol Transdermal System Consumption Market Share by Application (2014-2019)
8 Estradiol Transdermal System Major Manufacturers Analysis
- 8.1 Novartis
- 8.1.1 Novartis Estradiol Transdermal System Production Sites and Area Served
- 8.1.2 Novartis Product Introduction, Application and Specification
- 8.1.3 Novartis Estradiol Transdermal System Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Allergan
- 8.2.1 Allergan Estradiol Transdermal System Production Sites and Area Served
- 8.2.2 Allergan Product Introduction, Application and Specification
- 8.2.3 Allergan Estradiol Transdermal System Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bayer
- 8.3.1 Bayer Estradiol Transdermal System Production Sites and Area Served
- 8.3.2 Bayer Product Introduction, Application and Specification
- 8.3.3 Bayer Estradiol Transdermal System Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Noven Therapeutics
- 8.4.1 Noven Therapeutics Estradiol Transdermal System Production Sites and Area Served
- 8.4.2 Noven Therapeutics Product Introduction, Application and Specification
- 8.4.3 Noven Therapeutics Estradiol Transdermal System Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Mylan
- 8.5.1 Mylan Estradiol Transdermal System Production Sites and Area Served
- 8.5.2 Mylan Product Introduction, Application and Specification
- 8.5.3 Mylan Estradiol Transdermal System Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Vertical Pharmaceuticals
- 8.6.1 Vertical Pharmaceuticals Estradiol Transdermal System Production Sites and Area Served
- 8.6.2 Vertical Pharmaceuticals Product Introduction, Application and Specification
- 8.6.3 Vertical Pharmaceuticals Estradiol Transdermal System Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Perrigo Pharma International
- 8.7.1 Perrigo Pharma International Estradiol Transdermal System Production Sites and Area Served
- 8.7.2 Perrigo Pharma International Product Introduction, Application and Specification
- 8.7.3 Perrigo Pharma International Estradiol Transdermal System Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Estradiol Transdermal System Market
- 9.1 Global Estradiol Transdermal System Market Trend Analysis
- 9.1.1 Global Estradiol Transdermal System Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Estradiol Transdermal System Regional Market Trend
- 9.2.1 North America Estradiol Transdermal System Forecast 2019-2025
- 9.2.2 Europe Estradiol Transdermal System Forecast 2019-2025
- 9.2.3 China Estradiol Transdermal System Forecast 2019-2025
- 9.2.4 Japan Estradiol Transdermal System Forecast 2019-2025
- 9.2.5 Southeast Asia Estradiol Transdermal System Forecast 2019-2025
- 9.2.6 India Estradiol Transdermal System Forecast 2019-2025
- 9.3 Estradiol Transdermal System Market Trend (Product Type)
- 9.4 Estradiol Transdermal System Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Estradiol Transdermal System Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Estradiol Transdermal System. Industry analysis & Market Report on Estradiol Transdermal System is a syndicated market report, published as Global Estradiol Transdermal System Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Estradiol Transdermal System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
